Structure

Physi-Chem Properties

Molecular Weight:  360.23
Volume:  382.094
LogP:  3.132
LogD:  3.109
LogS:  -3.959
# Rotatable Bonds:  2
TPSA:  63.6
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.572
Synthetic Accessibility Score:  5.718
Fsp3:  0.818
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  2
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.801
MDCK Permeability:  5.9423626225907356e-05
Pgp-inhibitor:  0.204
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.346

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.063
Plasma Protein Binding (PPB):  80.25171661376953%
Volume Distribution (VD):  1.314
Pgp-substrate:  31.243303298950195%

ADMET: Metabolism

CYP1A2-inhibitor:  0.082
CYP1A2-substrate:  0.13
CYP2C19-inhibitor:  0.067
CYP2C19-substrate:  0.617
CYP2C9-inhibitor:  0.362
CYP2C9-substrate:  0.185
CYP2D6-inhibitor:  0.016
CYP2D6-substrate:  0.242
CYP3A4-inhibitor:  0.281
CYP3A4-substrate:  0.271

ADMET: Excretion

Clearance (CL):  3.572
Half-life (T1/2):  0.563

ADMET: Toxicity

hERG Blockers:  0.127
Human Hepatotoxicity (H-HT):  0.17
Drug-inuced Liver Injury (DILI):  0.114
AMES Toxicity:  0.03
Rat Oral Acute Toxicity:  0.946
Maximum Recommended Daily Dose:  0.953
Skin Sensitization:  0.661
Carcinogencity:  0.031
Eye Corrosion:  0.157
Eye Irritation:  0.72
Respiratory Toxicity:  0.966

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC210214

Natural Product ID:  NPC210214
Common Name*:   JSFOHQVKKXRNJH-NBTROFBBSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  JSFOHQVKKXRNJH-NBTROFBBSA-N
Standard InCHI:  InChI=1S/C22H32O4/c1-12-14-7-8-15-21(5)10-6-9-20(3,4)16(21)11-17(24)22(15,18(12)25)19(14)26-13(2)23/h14-17,19,24H,1,6-11H2,2-5H3/t14-,15+,16-,17-,19-,21+,22+/m1/s1
SMILES:  CC(=O)O[C@@H]1[C@@H]2CC[C@@H]3[C@]1([C@H](O)C[C@H]1[C@@]3(C)CCCC1(C)C)C(=O)C2=C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2337570
PubChem CID:   10618528
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0003782] Kaurane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[14510600]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[18161942]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. Vietnamese n.a. PMID[19899773]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[22085418]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. leaf n.a. PMID[22085418]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[22197145]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota whole plants Vietnam 2009-Aug PMID[23347584]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 2360.0 nM PMID[473149]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 1120.0 nM PMID[473149]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC210214 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.967 High Similarity NPC78427
0.967 High Similarity NPC16911
0.9667 High Similarity NPC13949
0.9565 High Similarity NPC287676
0.9462 High Similarity NPC163963
0.9462 High Similarity NPC289148
0.9462 High Similarity NPC52899
0.9362 High Similarity NPC304832
0.9362 High Similarity NPC76866
0.9362 High Similarity NPC148628
0.9362 High Similarity NPC286519
0.9362 High Similarity NPC88203
0.9362 High Similarity NPC214946
0.9362 High Similarity NPC246736
0.9333 High Similarity NPC294263
0.9263 High Similarity NPC87927
0.9263 High Similarity NPC470310
0.9231 High Similarity NPC47853
0.9222 High Similarity NPC250753
0.9205 High Similarity NPC165895
0.9167 High Similarity NPC98603
0.9111 High Similarity NPC470378
0.9111 High Similarity NPC180849
0.9111 High Similarity NPC261994
0.9111 High Similarity NPC149761
0.9062 High Similarity NPC216114
0.9053 High Similarity NPC46848
0.9043 High Similarity NPC471038
0.9032 High Similarity NPC329910
0.9011 High Similarity NPC299185
0.8977 High Similarity NPC102292
0.8969 High Similarity NPC84928
0.8958 High Similarity NPC275990
0.8925 High Similarity NPC205173
0.8925 High Similarity NPC98639
0.8925 High Similarity NPC470232
0.8925 High Similarity NPC470229
0.8913 High Similarity NPC59170
0.8913 High Similarity NPC473690
0.8913 High Similarity NPC144739
0.8913 High Similarity NPC471902
0.8913 High Similarity NPC59350
0.8913 High Similarity NPC181594
0.8913 High Similarity NPC287118
0.8889 High Similarity NPC112895
0.8889 High Similarity NPC231278
0.8889 High Similarity NPC218123
0.8878 High Similarity NPC265127
0.8854 High Similarity NPC471790
0.8842 High Similarity NPC162459
0.8842 High Similarity NPC20479
0.8842 High Similarity NPC38471
0.8842 High Similarity NPC38296
0.8842 High Similarity NPC98837
0.8842 High Similarity NPC474793
0.8842 High Similarity NPC28864
0.883 High Similarity NPC104568
0.883 High Similarity NPC29410
0.883 High Similarity NPC200054
0.8817 High Similarity NPC470386
0.8817 High Similarity NPC29247
0.8817 High Similarity NPC261333
0.8817 High Similarity NPC111524
0.8817 High Similarity NPC101233
0.8817 High Similarity NPC91772
0.8817 High Similarity NPC153775
0.8817 High Similarity NPC104371
0.8817 High Similarity NPC129004
0.8817 High Similarity NPC289539
0.8817 High Similarity NPC475118
0.8817 High Similarity NPC215271
0.8817 High Similarity NPC470385
0.8817 High Similarity NPC292374
0.8817 High Similarity NPC64006
0.8804 High Similarity NPC471901
0.8804 High Similarity NPC198242
0.8804 High Similarity NPC475416
0.8804 High Similarity NPC211403
0.8804 High Similarity NPC476168
0.8791 High Similarity NPC471043
0.8791 High Similarity NPC57954
0.8791 High Similarity NPC213832
0.8778 High Similarity NPC134197
0.8778 High Similarity NPC174619
0.8776 High Similarity NPC474558
0.8776 High Similarity NPC202793
0.8763 High Similarity NPC309388
0.8763 High Similarity NPC475803
0.875 High Similarity NPC291320
0.875 High Similarity NPC471036
0.875 High Similarity NPC293866
0.875 High Similarity NPC471037
0.8737 High Similarity NPC10864
0.8723 High Similarity NPC231060
0.8723 High Similarity NPC29112
0.8723 High Similarity NPC138245
0.8723 High Similarity NPC84018
0.87 High Similarity NPC273155
0.87 High Similarity NPC211224
0.8696 High Similarity NPC80401
0.8687 High Similarity NPC200957
0.8687 High Similarity NPC4115
0.8687 High Similarity NPC138908
0.8687 High Similarity NPC37600
0.8681 High Similarity NPC474719
0.8681 High Similarity NPC146937
0.8681 High Similarity NPC471900
0.8673 High Similarity NPC209298
0.8673 High Similarity NPC277074
0.8673 High Similarity NPC139347
0.8673 High Similarity NPC122811
0.8667 High Similarity NPC471042
0.866 High Similarity NPC473514
0.866 High Similarity NPC148279
0.866 High Similarity NPC236585
0.8646 High Similarity NPC89099
0.8636 High Similarity NPC110780
0.8632 High Similarity NPC470387
0.8632 High Similarity NPC135548
0.8632 High Similarity NPC264979
0.8632 High Similarity NPC140242
0.8627 High Similarity NPC329953
0.8617 High Similarity NPC302008
0.8617 High Similarity NPC191094
0.8602 High Similarity NPC278106
0.8602 High Similarity NPC470230
0.86 High Similarity NPC176949
0.86 High Similarity NPC201908
0.86 High Similarity NPC166993
0.8586 High Similarity NPC96268
0.8586 High Similarity NPC13149
0.8571 High Similarity NPC33768
0.8571 High Similarity NPC259009
0.8571 High Similarity NPC269360
0.8571 High Similarity NPC264005
0.8557 High Similarity NPC470388
0.8557 High Similarity NPC108371
0.8556 High Similarity NPC471034
0.8556 High Similarity NPC190704
0.8542 High Similarity NPC253586
0.8529 High Similarity NPC471093
0.8526 High Similarity NPC266431
0.8511 High Similarity NPC82138
0.85 High Similarity NPC295366
0.85 High Similarity NPC12823
0.8495 Intermediate Similarity NPC169933
0.8485 Intermediate Similarity NPC96217
0.8485 Intermediate Similarity NPC159442
0.8478 Intermediate Similarity NPC183374
0.8478 Intermediate Similarity NPC211162
0.8478 Intermediate Similarity NPC56413
0.8478 Intermediate Similarity NPC4309
0.8469 Intermediate Similarity NPC252614
0.8469 Intermediate Similarity NPC71706
0.8469 Intermediate Similarity NPC121218
0.8469 Intermediate Similarity NPC253886
0.8462 Intermediate Similarity NPC471252
0.8462 Intermediate Similarity NPC12774
0.8462 Intermediate Similarity NPC2783
0.8454 Intermediate Similarity NPC26270
0.8447 Intermediate Similarity NPC470281
0.8447 Intermediate Similarity NPC29505
0.8444 Intermediate Similarity NPC146683
0.8438 Intermediate Similarity NPC234564
0.8438 Intermediate Similarity NPC120708
0.8438 Intermediate Similarity NPC327788
0.8431 Intermediate Similarity NPC102741
0.8421 Intermediate Similarity NPC169751
0.8421 Intermediate Similarity NPC272635
0.8416 Intermediate Similarity NPC67745
0.8416 Intermediate Similarity NPC471461
0.8404 Intermediate Similarity NPC160506
0.84 Intermediate Similarity NPC301787
0.8387 Intermediate Similarity NPC77001
0.8387 Intermediate Similarity NPC253618
0.8384 Intermediate Similarity NPC136289
0.8384 Intermediate Similarity NPC170615
0.837 Intermediate Similarity NPC153604
0.8367 Intermediate Similarity NPC94906
0.8367 Intermediate Similarity NPC291785
0.8367 Intermediate Similarity NPC156324
0.8367 Intermediate Similarity NPC127408
0.8367 Intermediate Similarity NPC55503
0.8367 Intermediate Similarity NPC267921
0.8365 Intermediate Similarity NPC474927
0.8352 Intermediate Similarity NPC76518
0.8352 Intermediate Similarity NPC264317
0.8352 Intermediate Similarity NPC294438
0.8352 Intermediate Similarity NPC201655
0.8351 Intermediate Similarity NPC89225
0.8333 Intermediate Similarity NPC469729
0.8333 Intermediate Similarity NPC469733
0.8333 Intermediate Similarity NPC469599
0.8333 Intermediate Similarity NPC288906
0.8333 Intermediate Similarity NPC63841
0.8333 Intermediate Similarity NPC263135
0.8333 Intermediate Similarity NPC55973
0.8333 Intermediate Similarity NPC118800
0.8333 Intermediate Similarity NPC245866
0.8317 Intermediate Similarity NPC222833

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC210214 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8404 Intermediate Similarity NPD8035 Phase 2
0.8404 Intermediate Similarity NPD8034 Phase 2
0.8352 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD6399 Phase 3
0.7981 Intermediate Similarity NPD6881 Approved
0.7981 Intermediate Similarity NPD6899 Approved
0.7961 Intermediate Similarity NPD6402 Approved
0.7961 Intermediate Similarity NPD7128 Approved
0.7961 Intermediate Similarity NPD5739 Approved
0.7961 Intermediate Similarity NPD6675 Approved
0.7935 Intermediate Similarity NPD4788 Approved
0.7925 Intermediate Similarity NPD6650 Approved
0.7925 Intermediate Similarity NPD6649 Approved
0.7905 Intermediate Similarity NPD6373 Approved
0.7905 Intermediate Similarity NPD6372 Approved
0.789 Intermediate Similarity NPD7115 Discovery
0.7885 Intermediate Similarity NPD5697 Approved
0.7857 Intermediate Similarity NPD7748 Approved
0.7835 Intermediate Similarity NPD7515 Phase 2
0.783 Intermediate Similarity NPD7102 Approved
0.783 Intermediate Similarity NPD7290 Approved
0.783 Intermediate Similarity NPD6883 Approved
0.781 Intermediate Similarity NPD7320 Approved
0.78 Intermediate Similarity NPD6084 Phase 2
0.78 Intermediate Similarity NPD6083 Phase 2
0.78 Intermediate Similarity NPD7902 Approved
0.7757 Intermediate Similarity NPD6869 Approved
0.7757 Intermediate Similarity NPD6617 Approved
0.7757 Intermediate Similarity NPD6847 Approved
0.7757 Intermediate Similarity NPD8130 Phase 1
0.7753 Intermediate Similarity NPD6117 Approved
0.7736 Intermediate Similarity NPD6013 Approved
0.7736 Intermediate Similarity NPD6012 Approved
0.7736 Intermediate Similarity NPD6014 Approved
0.7714 Intermediate Similarity NPD5701 Approved
0.7685 Intermediate Similarity NPD6882 Approved
0.7685 Intermediate Similarity NPD8297 Approved
0.7684 Intermediate Similarity NPD3618 Phase 1
0.7667 Intermediate Similarity NPD6116 Phase 1
0.766 Intermediate Similarity NPD4786 Approved
0.7653 Intermediate Similarity NPD6079 Approved
0.7642 Intermediate Similarity NPD6011 Approved
0.7629 Intermediate Similarity NPD5328 Approved
0.7582 Intermediate Similarity NPD6118 Approved
0.7582 Intermediate Similarity NPD6115 Approved
0.7582 Intermediate Similarity NPD6114 Approved
0.7582 Intermediate Similarity NPD6697 Approved
0.7549 Intermediate Similarity NPD7638 Approved
0.7549 Intermediate Similarity NPD4225 Approved
0.7549 Intermediate Similarity NPD5696 Approved
0.7528 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7526 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6684 Approved
0.75 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7334 Approved
0.75 Intermediate Similarity NPD7146 Approved
0.75 Intermediate Similarity NPD7521 Approved
0.75 Intermediate Similarity NPD6409 Approved
0.75 Intermediate Similarity NPD7900 Approved
0.75 Intermediate Similarity NPD5330 Approved
0.7476 Intermediate Similarity NPD7640 Approved
0.7476 Intermediate Similarity NPD7639 Approved
0.7476 Intermediate Similarity NPD5285 Approved
0.7476 Intermediate Similarity NPD5286 Approved
0.7476 Intermediate Similarity NPD4696 Approved
0.7451 Intermediate Similarity NPD4755 Approved
0.7447 Intermediate Similarity NPD3667 Approved
0.7431 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7426 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7426 Intermediate Similarity NPD5695 Phase 3
0.74 Intermediate Similarity NPD4202 Approved
0.7368 Intermediate Similarity NPD6319 Approved
0.7353 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD4697 Phase 3
0.7353 Intermediate Similarity NPD5222 Approved
0.7353 Intermediate Similarity NPD5221 Approved
0.7347 Intermediate Similarity NPD6672 Approved
0.7347 Intermediate Similarity NPD5737 Approved
0.7347 Intermediate Similarity NPD6903 Approved
0.7333 Intermediate Similarity NPD5226 Approved
0.7333 Intermediate Similarity NPD5225 Approved
0.7333 Intermediate Similarity NPD5224 Approved
0.7333 Intermediate Similarity NPD4633 Approved
0.7333 Intermediate Similarity NPD5211 Phase 2
0.7321 Intermediate Similarity NPD6274 Approved
0.7308 Intermediate Similarity NPD4700 Approved
0.7303 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.73 Intermediate Similarity NPD6411 Approved
0.7292 Intermediate Similarity NPD3666 Approved
0.7292 Intermediate Similarity NPD3665 Phase 1
0.7292 Intermediate Similarity NPD3133 Approved
0.729 Intermediate Similarity NPD6008 Approved
0.7282 Intermediate Similarity NPD5173 Approved
0.7281 Intermediate Similarity NPD7101 Approved
0.7281 Intermediate Similarity NPD7100 Approved
0.7273 Intermediate Similarity NPD4753 Phase 2
0.7265 Intermediate Similarity NPD7492 Approved
0.7264 Intermediate Similarity NPD5174 Approved
0.7264 Intermediate Similarity NPD5175 Approved
0.7255 Intermediate Similarity NPD4629 Approved
0.7255 Intermediate Similarity NPD5210 Approved
0.7238 Intermediate Similarity NPD5223 Approved
0.7227 Intermediate Similarity NPD7736 Approved
0.7217 Intermediate Similarity NPD6054 Approved
0.7203 Intermediate Similarity NPD6616 Approved
0.7196 Intermediate Similarity NPD5141 Approved
0.7193 Intermediate Similarity NPD6335 Approved
0.7182 Intermediate Similarity NPD4634 Approved
0.7168 Intermediate Similarity NPD6868 Approved
0.7156 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7078 Approved
0.7143 Intermediate Similarity NPD4632 Approved
0.7111 Intermediate Similarity NPD5777 Approved
0.7105 Intermediate Similarity NPD6317 Approved
0.71 Intermediate Similarity NPD6904 Approved
0.71 Intermediate Similarity NPD6101 Approved
0.71 Intermediate Similarity NPD6080 Approved
0.71 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.71 Intermediate Similarity NPD6673 Approved
0.7094 Intermediate Similarity NPD6370 Approved
0.7079 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD6059 Approved
0.7053 Intermediate Similarity NPD7525 Registered
0.7043 Intermediate Similarity NPD6313 Approved
0.7043 Intermediate Similarity NPD6314 Approved
0.703 Intermediate Similarity NPD5785 Approved
0.7009 Intermediate Similarity NPD6016 Approved
0.7009 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7009 Intermediate Similarity NPD7632 Discontinued
0.7009 Intermediate Similarity NPD6908 Approved
0.7009 Intermediate Similarity NPD6909 Approved
0.7009 Intermediate Similarity NPD6015 Approved
0.7 Intermediate Similarity NPD4245 Approved
0.7 Intermediate Similarity NPD5128 Approved
0.7 Intermediate Similarity NPD4244 Approved
0.7 Intermediate Similarity NPD8293 Discontinued
0.7 Intermediate Similarity NPD4729 Approved
0.7 Intermediate Similarity NPD4730 Approved
0.6991 Remote Similarity NPD8133 Approved
0.699 Remote Similarity NPD6001 Approved
0.6979 Remote Similarity NPD5369 Approved
0.6972 Remote Similarity NPD4768 Approved
0.6972 Remote Similarity NPD4767 Approved
0.697 Remote Similarity NPD6098 Approved
0.6961 Remote Similarity NPD7637 Suspended
0.6961 Remote Similarity NPD5281 Approved
0.6961 Remote Similarity NPD5284 Approved
0.6957 Remote Similarity NPD6009 Approved
0.6949 Remote Similarity NPD5988 Approved
0.6944 Remote Similarity NPD4754 Approved
0.6939 Remote Similarity NPD3668 Phase 3
0.6932 Remote Similarity NPD4224 Phase 2
0.6923 Remote Similarity NPD6081 Approved
0.6909 Remote Similarity NPD6412 Phase 2
0.6907 Remote Similarity NPD4221 Approved
0.6907 Remote Similarity NPD4223 Phase 3
0.69 Remote Similarity NPD3573 Approved
0.6891 Remote Similarity NPD7604 Phase 2
0.6891 Remote Similarity NPD8328 Phase 3
0.6889 Remote Similarity NPD3698 Phase 2
0.6885 Remote Similarity NPD7319 Approved
0.6882 Remote Similarity NPD3703 Phase 2
0.6882 Remote Similarity NPD3702 Approved
0.6875 Remote Similarity NPD5249 Phase 3
0.6875 Remote Similarity NPD5248 Approved
0.6875 Remote Similarity NPD5250 Approved
0.6875 Remote Similarity NPD5247 Approved
0.6875 Remote Similarity NPD5251 Approved
0.6869 Remote Similarity NPD5363 Approved
0.6869 Remote Similarity NPD5329 Approved
0.6864 Remote Similarity NPD5983 Phase 2
0.6832 Remote Similarity NPD5208 Approved
0.6814 Remote Similarity NPD5215 Approved
0.6814 Remote Similarity NPD5217 Approved
0.6814 Remote Similarity NPD5216 Approved
0.6813 Remote Similarity NPD4789 Approved
0.681 Remote Similarity NPD8295 Clinical (unspecified phase)
0.68 Remote Similarity NPD5279 Phase 3
0.6796 Remote Similarity NPD6050 Approved
0.6796 Remote Similarity NPD5693 Phase 1
0.6786 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6778 Remote Similarity NPD5361 Clinical (unspecified phase)
0.6778 Remote Similarity NPD5360 Phase 3
0.6777 Remote Similarity NPD7507 Approved
0.6777 Remote Similarity NPD6336 Discontinued
0.6771 Remote Similarity NPD7645 Phase 2
0.6768 Remote Similarity NPD4197 Approved
0.6765 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6762 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6735 Remote Similarity NPD4270 Approved
0.6735 Remote Similarity NPD4269 Approved
0.6735 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6731 Remote Similarity NPD5778 Approved
0.6731 Remote Similarity NPD5779 Approved
0.6726 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6726 Remote Similarity NPD5135 Approved
0.6726 Remote Similarity NPD5169 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data